
倧æè£œè¬äŒç€Ÿã¯ãRFKãžã¥ãã¢ãCOVIDã¯ã¯ãã³ã«ããè² å·ã«å¯Ÿããè£åæ¹åèšç»ãææ¡ããããšãåããŠåçº
å èšäºã¯ãã¡ããã/Click here to read the original article.
å é±ãç±³åœä¿å¥é·å®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ã¯ãCOVID-19ã¯ã¯ãã³ã«ãã£ãŠè² å·ããã¢ã¡ãªã«äººãè£åããé£éŠè³éã«ããããã°ã©ã ã®èŠå倿Žãææ¡ããŸãããããã«å¯Ÿããã±ããã£ã«å¯Ÿãã蚎èšã§è£œè¬è³éã«ããã¢ã¡ãªã«å°å ç§åŠäŒã代衚ãã䞻任åŒè·å£«ãªãã£ãŒãã»ãã¥ãŒãº4äžã¯ããã®èšç»ãæ¹å€ãããã¶ã»ãã«ãã«å¯Ÿããè£åãããCOVID-19ã¯ã¯ãã³æ¥çš®è ãå€ããããšã¯ã¯ãã³ãžã®ãããããçããå¯èœæ§ããããšèªã£ãã
ã«ã€ã»ã³ã³ãè
å 鱿«ãç±³åœä¿å¥é·å®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ã¯ãCOVID-19ã¯ã¯ãã³ããã®ä»ã®COVID-19ãŠã€ã«ã¹å¯Ÿçã§æå®³åå¿ãèµ·ãããã¢ã¡ãªã«äººãè£åããããã®é£éŠè³éã«ããããã°ã©ã ã§ãã察æå·å®³è£åããã°ã©ã (CICP)ã®èŠå倿Žãææ¡ããŸããã
é·å®ã¯ãŸããCOVID-19ã¯ã¯ãã³ã«ããè² å·è ã®æ°ããªãªã¹ããææ¡ããŠããŸãã
ãªã¹ããèŠå®ããèŠåã®å€æŽã¹ã±ãžã¥ãŒã«ã¯11æã§ãæèŠåéæéã¯2027幎1æãŸã§å»¶é·ãããŸããCICPã¯2010幎ã«H1N1ã¯ã¯ãã³ã«ããå·å®³ã«å¯Ÿå¿ããããã«èšç«ãããŸãããç®ç«ããã«é²ãã§ãããã ã
ãªãã§ãããã?å»çå°éå®¶ãæ£è ã«ã¯ã¯ãã³è¢«å®³ã®å ±éãã»ãšãã©äŒããªãããã§ãããããŠã倧æè£œè¬äŒç€Ÿã®é·ãè ã¯ãåŸæ¥ã®ã¡ãã£ã¢ã§ã®åºç¯ãªåºåã«ãã£ãŠåŒ·åãããå·§åŠã«ãã®ãããªã¡ãã£ã¢ãã¯ã¯ãã³è¢«å®³ã®å ±éã劚ããŠããããã§ãã
ããã¯å°ããªèŠèœãšãã§ã¯ãããŸããã2010幎ã®èšç«ä»¥æ¥ã人äºãµãŒãã¹å±(HRSA)ã¯ãããŸã§ã«14,755ä»¶ã®è«æ±ãCICPã«å ±åããŠããŸããè£åãåããã®ã¯ããã92人ã§ããã®çã¯1%æªæºã§ãããã®ããã°ã©ã ã¯æ©èœãããäžè¬åžæ°ã«ããµãŒãã¹ãæäŸããŠããŸããã
ã±ããã£ãå€é©ãæ±ããã®ã¯æ£ããããšã§ããã圌ã¯ãŸãã«ãããè¡ãããã®æç¶ãã«åŸã£ãŠããŸãã
æ°ããèŠåã¯ã管çäºç®å±(OMO)åäžã®æ å ±èŠå¶å±(Office of Information and Regulatory Affairs)ã«ãã£ãŠçºè¡šãããæ¬¡ã®ããã«èŠå®ãããŠããŸãã
ãå ¬å ±æºåã»ç·æ¥æºåæ³(PREPæ³)ã¯ãHHSé·å®ã«å¯ŸããPREPæ³ã«åºã¥ã宣èšã§æå®ããã察象察çã®å®æœãŸãã¯äœ¿çšã«ãããé節ãªèº«äœçå·å®³ãæ»äº¡ã被ã£ãç¹å®ã®è ã«çµŠä»ãæäŸããCICPãèšç«ããæš©éãäžããŸããã
ãããã«ãé·å®ã¯ãè£å察象ã®è² å·ãå¥åº·äžã®å䜵çã«ãã£ãŠçŽæ¥äº¡ããªã£ãå人ã®ç¹å®ã®éºæã«æ»äº¡çµŠä»ãæ¯çµŠããããšããããŸããã
ç°¡åã«èšãã°ãã«ããŒããã察ç(äž»ã«COVID-19ã¯ã¯ãã³)ãåãããã€ã«ãŠã³ã¿ãŒã¡ãžã£ãŒå·å®³è¡šã«èšèŒãããæéå ã«è² å·ãè² ã£ãããšã蚌æã§ããè ã¯è£åãåããè³æ ŒããããŸãã

ãã®è¡šã§ã¯ã説åŸåãããä¿¡é Œæ§ãé«ããæå¹ãªå»ççããã³ç§åŠç蚌æ ã«åºã¥ãæªæã®è©³çްã瀺ããŸãããã®ãããªæªæã¯ã察象ãšãªãCOVID-19察çã«ãããã®ãšæšå®ãããŸãã
æ°ããã«ãŒã«ã¯åççãªèšç»ã§ãã察çå·å®³è¡šã¯ã1980幎代åŸåã«å šåœå°å ã¯ã¯ãã³å·å®³æ³ãè£åããã°ã©ã ãèšç«ããéã®å ã®ã¯ã¯ãã³å·å®³è¡šãããªãã¡å šåœã¯ã¯ãã³å·å®³è£åããã°ã©ã (NVICP)ãšåæ§ã®ä»çµã¿ã§æ©èœããŸãã
ããã°ãã¡ãŒãã¯NVICPã®èšç«ããããŒæŽ»åããã¯ã¯ãã³ã«ããè² å·ã«é¢ãã蚎èšãã¯ã¯ãã³çç£äºæ¥ããæ€éããŠãããšäž»åŒµããŸããã
1986幎ãè°äŒã¯å šåœå°å ã¯ã¯ãã³å·å®³é²æ¢æ³ãããã«ãã»ã¬ãŒã¬ã³å€§çµ±é ã®æºã«æŒãä»ããåœŒã¯æžã 眲åããŸããã
ãã®æ³åŸã¯è£œè¬äŒç€Ÿã«æ°äºè²¬ä»»ã®å é€ãäžããæçµçã«ã¯çŸç 察çã»ã³ã¿ãŒ(CDC)ãåã©ããã¡ã«æ¥çš®ãæšå¥šããã¯ã¯ãã³ã®æ°ãå€§å¹ ã«å¢å ãããŸããã
ããã°ãã¡ãŒãã¯40幎åãšåããããªCOVID-19ã¯ã¯ãã³ã«ããå·å®³ã«å¯Ÿããä¿è·ã享åããŠãããããã±ããã£ãææ¡ããæ°ããã¢ãã«ãæ¯æããã¯ãã ã
絶察ã«ç¡çã ã
ããã°ãã¡ãŒãã¯äŸç¶ãšããŠè²¬ä»»ããã®èªç±ãšã¯ã¯ãã³çŸ©ååã®åŒ·åãæ±ããŠããŸãããŸããã¯ã¯ãã³ã«ãã被害ã«ã€ããŠäžè¬ã®äººã ãã§ããã ãç¥ããªãããšãç¥ãããããšãèããŠããŸãã
ããã°ãã¡ãŒãããã®é£æºããå»çæ©é¢ã®ããŒãããŒã¯è² å·è ã«äžéãæ¯æããªãããè£åãåããŠããã¯ã¯ãã³è¢«å®³è ã¯ããžãã¹ã«ãšã£ãŠæªåœ±é¿ãåãŒããŠããã
ã±ããã£å€§çµ±é ã®å°å ã¯ã¯ãã³ã¹ã±ãžã¥ãŒã«å€æŽã«ç°è°ãå±ãã補è¬äŒç€Ÿè³éã«ããã¢ã¡ãªã«å°å ç§åŠäŒ(AAP)蚎èšã代衚ãã䞻任åŒè·å£«ãªãã£ãŒãã»ãã¥ãŒãº4äžã¯ãè£åãåããCOVID-19ã¯ã¯ãã³è¢«å®³è ãéå°ã«å€ããããšã¯ã¯ãã³ãžã®ãããããçããå¯èœæ§ããããšäž»åŒµãããã®ç¹ãè¿°ã¹ãŸããã
ãã¥ãŒãºã¯The Hillã§åŒçšãããç±³åœä¿å¥çŠç¥çãCOVID-19ã¯ã¯ãã³ã«ããè² å·ã®æ¡å€§è¡šã«é床ã«åºç¯ãªç ç¶ãæããŠããããšã«æžå¿µã瀺ããŸããã
ãççŽã«èšãã°ãã¿ã€ãã³ã°ã ãã§ã¯ååã§ã¯ãããŸããããšåœŒã¯èªããŸããããçãã ãã§ã¯è¶³ããªããæ¿æ²»çå§åã ãã§ã¯äžååã§ãããã®æ³åŸã¯çŽæ¥çãªå æé¢ä¿ã瀺ã匷åãªå»åŠçã»ç§åŠç蚌æ ãæ±ããŠãããã
çå®ã¯ãç±³åœé£åå»è¬åå±(FDA)çç©è£œå€è©äŸ¡ç ç©¶ã»ã³ã¿ãŒã®å æé·ã§ããããŒã¿ãŒã»ããŒã¯ã¹å士ãå«ãè£œè¬æ¥çã®ååè ãã¡ã¯ãã±ããã£ã«ã¯ã¯ãã³è¢«å®³ããŒã¿ãé ããŠããã®ã§ãã
ããã±ããã£ãèŠå倿Žã®èšŽãã§COVID-19ã¯ã¯ãã³ã«ããè² å·è ã®ãªã¹ããæ¡å€§ããããšã«æåããã°ãã¢ã¡ãªã«åœæ°ãåè ãšãªãã§ããããç§ãã¡ã¯ã€ãã«COVID-19ã¯ã¯ãã³ã«ããè² å·ã®æ°ãšéç床ã«ã€ããŠçå®ãç¥ãããšãã§ããã®ã§ãã
ãCOVID-19ã¯ã¯ãã³ã®å°å ¥ã§ã¯ãé«åºŠãªã¢ã«ãŽãªãºã ã¯å¿ èŠãªãã£ãããšãã³ã»ãžã§ã³ãœã³äžé¢è°å¡(å ±åå ã»ãŠã£ã¹ã³ã³ã·ã³å·éžåº)ã¯æè¿è¿°ã¹ãã
ãVAERSãå§åãã倧éã®æå®³äºè±¡å ±åã¯ãç§ã®ç£ç£æŽ»åãçºåãããã«ååã§ãããç§ãã¡ã¯ãã±ããã£åœåé·å®ã®æ¥é²çéææ§ãžã®ã³ãããã¡ã³ããç§ã®å°å§å¡äŒã«1,100äžããŒãžã®ææžãæäŸãããŸã§ãçªç Žäžå¯èœãªå£å£ã«çŽé¢ããŸãããã
åŒè·å£«ãã¥ãŒãºãAAPã倧æè£œè¬äŒç€Ÿãããªãã«èŠããããªãã®ã¯ã1100äžããŒãžã«åã¶ã¯ã¯ãã³è¢«å®³ã«é¢ããææžã§ããã ããããããžã§ã³ãœã³ãã±ããã£ãšå ±ã«ãç§ãã¡ã¯çå®ã®ããã«æŠãç¶ããªããã°ãªããªãçç±ã§ãã